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Abstract 
Background: To study the safety, feasibility and skin effects of irreversible electroporation (IRE) for breast tissue and 
breast cancer in animal models.
Methods: Eight pigs were used in this study. IRE was performed on the left breasts of the pigs with different skin–
electrode distances, and the right breasts were used as controls. The electrodes were placed 1–8 mm away from the 
skin, with an electrode spacing of 1.5–2 cm. Imaging and pathological examinations were performed at specific time 
points for follow-up evaluation. Vital signs, skin damage, breast tissue changes and ablation efficacy were also closely 
observed. Eight rabbit models with or without VX2 breast tumor implantations were used to further assess the dam-
age caused by and the repair of thin skin after IRE treatment for breast cancer. Contrast-enhanced ultrasound and 
elastosonography were used to investigate ablation efficacy and safety.
Results: During IRE, the color of the pig breast skin reversibly changed. When the skin–electrode distance was 3 mm, 
the breast skin clearly changed, becoming white in the center and purple in the surrounding region during IRE. One 
small purulent skin lesion was detected several days after IRE. When the skin–electrode distance was 5–8 mm, the 
breast skin became red during IRE. However, the skin architecture was normal when evaluated using gross pathology 
and hematoxylin-eosin staining. When the skin–electrode distance was 1 mm, skin atrophy and yellow glabrescence 
occurred in the rabbit breasts after IRE. When the skin–electrode distance was ≥5 mm, there was no skin damage in 
the rabbit model regardless of breast cancer implantation. After IRE, complete ablation of the targeted breast tissue or 
cancer was confirmed, and apoptosis was detected in the target tissue and outermost epidermal layer. In the ablated 
breasts of the surviving animals, complete mammary regeneration with normal skin and hair was observed. Further-
more, no massive fibrosis or mass formation were detected on ultrasound or through hematoxylin–eosin staining.
Conclusions: After IRE, the skin architecture was well preserved when the skin–electrode distance was ≥5 mm. 
Moreover, breast regeneration occurred without mass formation or obvious fibrosis.
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Background
In recent years, the use of breast-conserving therapy has 
been supported by clinical evidence, and image-guided 
ablation techniques, such as radiofrequency ablation 
[1, 2] and high-intensity focused ultrasound [3], have 
emerged as useful modalities for the treatment of breast 
tumors. During breast cancer ablation, if a lesion is too 
large or is superficial, breast skin can become damaged, 
and incomplete ablation might occur in an attempt to 
prevent such damage. In addition, many Asian women 
exhibit a relatively small breast volume, and thus the risk 
for skin injury during thermal ablation is increased in this 
population [4].
Thermal ablation causes a breast tumor to undergo 
coagulative necrosis. During this process, the original 
ablation area is gradually substituted postoperatively by 
fibrous tissue, creating a mass in the breast [5, 6]. This 
mass might result from inflammation, fibrotic formation, 
tumor recurrence or fat necrosis. If a breast mass devel-
ops, residual tumors must be excluded, which can exac-
erbate the patient’s psychological burden [1].
Radiation-induced fibrosis after breast-conserving 
therapy (i.e., fibrosis of breast and skin) is a common 
late toxicity after radiotherapy. Approximately 45  % of 
patients have experienced radiation-induced fibrosis-
related pain, and more severe fibrosis might be induced 
after resection of tissues with radiation-induced fibrosis 
[7]. This is a major factor affecting quality of life and cos-
metic results after radiotherapy for breast cancer [8–10].
After breast cancer ablation, if the skin has not been 
damaged and normal breast tissue has regenerated with-
out mass formation or a residual tumor, then the above- 
mentioned problems would be resolved. The application 
of irreversible electroporation (IRE) makes this goal pos-
sible, as apoptosis of the skin can be selective after IRE. 
There have been no reports examining the use of IRE 
for ablation of breast cancer in a large animal model, 
although some efforts have been made [11, 12]. The pre-
vious studies [11, 12] mainly reported the efficacy of IRE, 
but we focused on skin damage, fibrotic mass formation 
and mass reabsorption in the breast after IRE ablation.
In this study, we performed IRE on two large animal 
breast and breast cancer models, with electrodes placed 
close to the skin surface (1–8  mm). We evaluated the 
safety and feasibility of IRE, particularly regarding its 
potential to damage skin and induce fibrotic mass forma-
tion in the breast.
Methods
Approval for the use of animals in this study was obtained 
from the Animal Care Committee of Sun Yat-sen Univer-
sity Cancer Center. Wuzhishan pigs were used to study 
IRE ablation on normal breasts, and New Zealand great 
white rabbits were used to investigate IRE ablation of 
breast skin and breast cancer. A description of the design 
of the study is shown in Table 1.
The pig breast is relatively large and has thick skin, 
which facilitated the accurate determination of the 
approximate distance between the electrode and the skin 
when IRE was performed.
The skin over a local breast cancer tumor can be differ-
ent from typical healthy skin; this thinning might result 
from malnutrition, skin invasion and local tumor ten-
sion. Thus, the risk of thermally damaging the skin dur-
ing IRE can increase. Because rabbit skin is thin, we used 
New Zealand great white rabbits to study skin damage 
after IRE. To accomplish this, we generated a VX2 tumor 
model in rabbits to examine the safety of IRE ablation of 
breast cancer. Dr. Sheng Li and Dr. Qi Zeng were respon-
sible for performing follow-up examinations to identify 
breast skin changes in these animals. Before and after 
IRE, the breast skin, nipple, muscle behind the breast, 
mammary duct and mammary glands were assessed in 
all of the animals via gross pathology and histopathol-
ogy, and mass formation in the breast, fibrosis in the 
ablation zone and breast regeneration were also assessed 
post-treatment.
Irreversible electroporation
All of the animals were fasted for 12 h prior to the pro-
cedure. Skin preparation, sterilization and draping were 
completed before the procedure. Each procedure began 
with intramuscular Telazol pre-medication (4.4  mg/kg), 
and after intubation, general anesthesia was maintained 
via intravenous injection of 3  % pentobarbital sodium 
(1 ml/kg). All of the animals were subcutaneously admin-
istered 0.01 mg/kg buprenorphine before the procedure 
and every 12 for 72 h thereafter as needed. Each animal 
also received succinylcholine (2 mg/kg) during IRE. Pan-
curonium (0.15  mg/kg) was administered intravenously 
10 min before IRE to reduce muscle contractions.
IRE was guided under computed tomography (CT) 
as well as ultrasound to ascertain the precise spacing 
between the skin and the electrode. An experienced tech-
nologist in the medical imaging department performed 
the CT and Magnetic Resonance Imaging (MRI) scans. 
Dr. Peihong Wu, a professor of radiology and oncology 
with 30  years of experience in diagnostic imaging, and 
Dr. Sheng Li, with 7 years of experience in medical imag-
ing and interventional radiology, analyzed the CT images 
together. Dr. Fei Chen, with 7  years of experience in 
ultrasound, performed the ultrasounds and analyzed the 
images with another trained doctor in the Department of 
Ultrasonography.
IRE electrodes were implanted into the proper posi-
tion in the breast with real-time ultrasound monitoring 
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(MyLab GOLD Platform, ESAOTE S.P.A., Italy). Our 
group has over 5  years of experience in interventional 
radiology. The nipple was located between two elec-
trodes, and most of the breast was located in the ablation 
zone in our study. Parallel electrodes and a proper loca-
tion were also confirmed by CT scanning (Fig. 1a). After 
complete muscle relaxation, we began IRE ablation using 
the electrocardiogram (ECG) synchronous mode.
A NanoKnife® system (software version 2.2.0, Angio-
dynamics®, Latham, NY, USA) was used with the follow-
ing parameters: two electrodes, ECG synchronization, 
90 pulses, a pulse length of 70 µs, an electrode spacing of 
1.5–2 cm, 1500 V/cm, and a tip exposure of 1.5 cm. After 
IRE, we reviewed the voltage and current graphs and the 
contrast-enhanced ultrasound and CT images to assess 
the ablation efficacy. If complete ablation of the targeted 
zone was not achieved, the IRE procedure was repeated.
IRE ablation of pig breasts
Eight healthy mature Wuzhishan pigs, 16–18  kg, were 
divided into an IRE group (six pigs) and a sham treat-
ment group (two pigs). Three left breasts in each pig 
were ablated or processed. The right breasts were used 
as controls; these received no treatment in any of the 
pigs. Electrodes were inserted into the left breasts with-
out performing ablation in the sham treatment group. 
IRE ablation was performed on the left breasts in the IRE 
group.
In the IRE group, the distance between the electrode 
and the skin was 3 mm for three breasts in one pig and 
between 5–8 mm in the remaining five pigs. The distance 
between the electrode and the skin was defined as the 
shortest distance between the exposed part of the elec-
trode and the skin surface as measured with CT imaging.
In the sham treatment group, the electrode was 
inserted into a predetermined position in the breast for 
the same time interval without performing ablation. CT 
and MRI were performed perioperatively, and we either 
performed a biopsy or resected the breasts for pathologi-
cal examination. Resection was performed immediately 
prior to an animal being sacrificed.
IRE ablation of rabbit breasts
To determine whether IRE ablation would damage thin 
skin, we placed electrodes close to the breast skin (1 or 
3  mm) in New Zealand great white rabbits. The elec-
trodes were maintained parallel to the skin plane, and 
the distance was 1 mm in four ablation zones and 3 mm 
in another four ablation zones. A total of eight sessions 
of IRE were performed on four rabbits. At 1, 3, 7 and 
14 days after IRE, Dr. Sheng Li and Qi Zeng followed up 
to examine mass formation, fibrosis and skin changes.
IRE of a breast cancer model
We sectioned fresh VX2 tumors into 1–2 mm diameter 
tissue blocks without necrosis or liquefaction pieces. 
Next, we implanted a fresh tumor under the breast skin 
of each of four rabbits. Two breast cancer models were 
generated in each rabbit. The skin–electrode distance 
was <8 mm.
After 1 week, all 8 breast tumors increased to 1–1.5 cm 
in diameter, and we assessed tumor size using ultrasound. 
Color Doppler ultrasound, elastosonography and con-
trast-enhanced ultrasound were performed before and 
1 and 7  days after IRE. We resected four breast tumors 
from four rabbits on the third day for pathologic exami-
nation; thus, no ultrasounds were performed on these 
resected tumors at later time points in the experiment. 
Table 1 Study design and observation items
Aim Skin electrode distance/
electrode spacing
Observation items Subgroups
Pig model To test irreversible elec-
troporation ablation of 
the breast





and imaging changes: 
apoptosis assays, skin 
and breast regeneration
IRE group: 6 pigs sham treatment group: 
2 pigs. Three left breasts in each pig 
were ablated or processed, and the 
right breasts were used as controls
Rabbit model To test irreversible elec-
troporation ablation of 
the breast with thin skin
1 mm in 4 ablation zones 




Safety and skin architecture 8 sessions of IRE performed in 4 rabbits
Rabbit model with 
breast cancer
To test irreversible elec-
troporation ablation of 
breast cancer with thin 
skin




Changes in pathology 





Two breast cancer models were gener-
ated in each rabbit
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The remaining 4 breast tumors were regularly assessed 
for at least 1 month.
We used contrast-enhanced ultrasound to assess 
whether complete ablation was achieved, and elasto-
sonography was used to detect changes in tissue stiff-
ness after IRE, as a potential method to assess complete 
ablation. For elastosonography (Surpersonic Aixplorer 
color Doppler ultrasonic diagnostic apparatus, Super-
sonic Shear Imaging Company, France), the probe fre-
quency was 4–15  MHz. After an appropriate section 
was selected, we switched to the real-time shear wave 
elastography model and placed an elastic imaging sam-
pling frame over the ablation zone. When image stabi-
lization was achieved after 3–5  s, we filled 90  % of the 
imaging sampling frame with color and selected a cycle 
of 3  cm in diameter as the measurement area to obtain 
the average elasticity value. Measurements were repeated 
three times. Leaving an ultrasound probe impression on 
the surface skin was avoided as much as possible. For 
contrast-enhanced ultrasound imaging, after a bolus 
injection of 1.2  ml microbubbles of sulfohexafluoride 
(SonoVue®, Bracco, Milano, Italy), we started approxi-
mately 2 min of imaging. The ultrasound frequency used 
was 3–9 MHz. Elastosonography and contrast-enhanced 
ultrasound were performed before and after IRE.
Hematoxylin‑eosin staining and immunohistochemistry
Two pathologists, each with more than 4 years of experi-
ence in our cancer center, performed all of the pathologi-
cal examinations. Breast specimens were harvested and 
Fig. 1 Breast skin changes after IRE. a–c (skin–electrode distance: 5 mm): Color changes in breast skin with different electrode distances. The skin 
initially turned red (a), then purple (b), and finally became white in the central zone (c) near the electrode. d IRE ablation performed very close to 
the superficial skin (skin–electrode distance of 3 mm). The skin was still purple and swollen after IRE. e, f: 2–3 months after IRE, the breast appeared 
normal
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fixed for HE staining and apoptosis assays. TdT-mediated 
dUTP Nick-End Labeling (TUNEL) and caspase-3 tests 
were performed immediately and 1, 3  days and 1  week 
after IRE to assess apoptosis.
The major reagents used were an In  Situ Cell Death 
Detection Kit, POD (Hoffmann-La Roche Inc. USA), a 
Caspase-3 polyclonal antibody for IHC (Thermo Fisher 
Scientific Inc. Rockford, IL US), and a 3,3′-diaminobenzi-
dine and Streptavidin peroxidase immunohistochemistry 
staining kit (Fuzhou Maixin Biotechnology Development 
Co., Ltd).
TUNEL and caspase-3 tests were used to detect mark-
ers of apoptosis. Positive TUNEL results were defined as 
brown-yellow nuclear staining. Positive staining for cas-
pase-3 protein was brown-yellow staining of cytoplasm. 
We assessed the apoptotic cell distributions in the skin, 
mammary vessels, muscle, mammary gland, duct and 
stroma.
Results
IRE ablation of pig breast
After IRE at a skin–electrode distance of 3 mm, the color 
of the skin on the pig breasts initially changed to red, 
then white, then purple, and finally returned to a normal 
color (Fig. 1a–d). After 2 weeks, there were small suppu-
rative foci in one area of skin. Scabs formed 4 weeks later, 
and the skin then returned to normal. The remaining two 
breasts were normal.
When the skin–electrode distance was approximately 
5–8  mm, the breast skin became red, and the central 
area of the ablation zone became white with a red color 
around the nipple. A closer skin–electrode distance led 
to more obvious and rapid intraoperative skin color 
changes. The skin color returned to normal after 2 h, and 
a small amount of liquid was visible as the puncture point 
became red.
After IRE, the ablated breasts became congestive, swollen 
and hard. Within 3 months, the majority of the animals had 
breast skin that appeared normal (Fig.  1e, f ), with intact 
hair and skin. No fibrous mass formation was detected in 
the ablation zone during the 3 months following IRE.
IRE ablation of rabbit breast and breast cancer
Before IRE, the breast skin on the rabbits appeared nor-
mal (Fig.  2a). When the skin–electrode distance was 
1 mm, the skin became red after IRE (Fig. 2b, c), and one 
small purulent lesion appeared on the third postoperative 
day (Fig. 2d). One week later, the skin exhibited chlorosis 
and shedding (Fig. 2e), and 2 weeks after IRE, new skin 
had regenerated, without scar formation. Three weeks 
later, only a small scab was present on the skin; new hair 
growth was evident in this area, and most of the skin in 
the ablation zone had recovered to normal. Two months 
after IRE, the breast tissues that surrounded the skin and 
muscle were normal. With regards to the other three 
breasts, the skin became dry and yellow, and trichomade-
sis occurred 1  week later. After 2  weeks, there were no 
suppurative foci, but new skin had grown, and 3  weeks 
later, the hair and skin were normal. When the skin–elec-
trode distance was 3 mm, the skin color of four ablation 
zones transiently changed to red, without skin architec-
ture damage or hair loss, and there was no scar or fibro-
sis formation in any of the rabbit breasts, which became 
swollen after IRE.
After the breast VX2 tumor model was established 
in rabbits, we confirmed tumor formation using patho-
logical assessment and ultrasound. The tumors gradually 
increased by 1–2  cm (Fig.  3a) in diameter 10  days after 
implantation, without liquefaction or necrosis. The first 
day after IRE (Fig. 3b), the breast tumors became hard-
ened and enlarged, and after the second day, the tumors 
began to soften and shrink in size in a time-dependent 
manner. When the skin–electrode distance was 1  mm, 
the skin on one breast exhibited signs of sepsis with scar 
healing. When the skin–electrode distance was approxi-
mately 3 mm, the breast skin covering the tumor became 
purulent, and no blood supply was detected in the ablated 
area. When the skin–electrode distance was  ≥5  mm, 
there were no signs of skin ulceration, suppuration or 
trichomadesis (Fig.  3c), and the intact skin architecture 
was well preserved. One month after IRE, all of the ani-
mals had breast skin that appeared normal (Fig. 3d).
Hematoxylin‑eosin staining
Immediately after IRE, the ablated breasts became con-
gested, swollen and hard. Surrounding the electrode 
tract, the breast color turned brownish-black (Fig.  4a). 
Immediately after IRE, vacuolation was observed in the 
glandular and ductal cells of the breasts. Two hours to 
3  days after IRE ablation, there was secretion of serous 
fluid from the breast ducts, shedding of some ductal cells 
and infiltration of neutrophils, eosinophils and plasmo-
cytes (Fig.  4b–d). No visible damage to the stratified 
squamous epithelium architecture of the breast skin was 
observed (Fig.  4e). Three days after IRE, fibroblasts and 
collagen formation were visible near the electrode path, 
and striated muscle fragmentation and dissolution were 
also visible (Fig. 4f ). One week after IRE, the sebaceous 
glands and hair in the skin within the ablation zone 
appeared normal (Fig. 4g–j).
Fourteen days after IRE, mammary gland regenera-
tion and restoration of normal breast tissue architecture 
without ductal narrowing, dilatation or occlusion were 
observed in the pig breasts (Fig. 4g). There was no mas-
sive fibrosis or mass formation in any of the ablation 
zones.
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A small amount of bleeding in the electrode path was 
found in both the sham treatment group and the control 
group, with some collagen fibers forming 3  weeks later 
(Fig.  5) without detectable apoptosis or inflammatory 
infiltration.
Two months after IRE, normal breast tissue was 
present in the previous ablation zones on the experi-
mental pigs (Fig.  4j), and no architectural abnormali-
ties were observed in the skin collagen, hair roots, 
sweat glands or sebaceous glands. Over a period of 
Fig. 2 Skin changes after IRE (skin–electrode distance of 1 mm). a Before IRE, the breast skin appeared normal. b Immediately after IRE, the skin 
became red and edematous. c Three days after IRE, the skin was still red in color. d Seven days after IRE, the hair had fallen out, but no suppurative 
foci were observed in the skin folds. e Skin scar remaining after IRE
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3  months, there was no mass formation or mammary 
duct occlusion.
For the IRE ablation of normal rabbits, when the skin–
electrode distance was within 1–3  mm, HE staining 
showed clean and intact collagen fibers and normal skin 
architecture. A homogenously red-stained area around 
the electrode passage was also observed. No fibrosis 
or mass formation was observed in any of the breasts 
2 weeks after IRE.
After performing IRE ablation of breast tumors, infil-
tration of inflammatory cells and a few erythrocytes was 
observed in the skin. The ablated breast tumors gradu-
ally resolved after 3 weeks without mass formation, and 
the previous ablation zones were replaced with normal 
breast tissue.
Apoptosis assays
Within three days of IRE, caspase-3-positive staining in 
the cytoplasm was detected in the ablation areas (Fig. 5a, 
b). For the pigs in the IRE group, positive TUNEL stain-
ing was detected in the nuclei of acinar cells, ductal 
epithelial cells, adipocytes, stromal cells, vascular 
endothelial cells and vascular smooth muscle cells in the 
breast (Fig.  5c, d), and the number of positively stained 
cells gradually increased in a time-dependent manner, 
with 100  % of cells undergoing apoptosis by the third 
day. No cell apoptosis was detected in the sham treat-
ment group or the control group. One week after IRE, 
there was negative staining in the breast and above the 
skin (Fig.  5e–h). Apoptosis of vascular endothelial cells 
and vascular smooth muscle cells in the breast was also 
detected in the IRE group (Fig.  6). Two hours after IRE 
ablation, a few apoptotic cells were visible in the outer-
most layer of epidermal squamous epithelial cells, and 
the number of apoptotic cells increased on the third day 
(Fig.  6a–d). Fourteen days after IRE, no apoptotic cells 
were detected in any of the breasts.
Imaging
Immediately after IRE, the ablated breasts was congested, 
swollen and enlarged, as confirmed by CT (Fig. 7a–c) and 
MR imaging (Fig. 7d–j), whereas the ablation zones were 
hypoechoic according to ultrasound assessment. One 
week after IRE, CT imaging showed the presence of mild 
hyperemia and edema in the pig breasts. After 2 months, 
ultrasounds of the ablated breast areas appeared nor-
mal. After IRE, the complete hierarchical architecture 
of the breast skin and breast tissue was observed using 
Fig. 3 IRE ablation of breast cancer. a A breast cancer model was constructed. b Two electrodes were placed into the tumor. c Immediately after 
IRE, the skin became red. d Two weeks after IRE, complete ablation of the tumor was confirmed, and the skin appeared normal with few hairs
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CT (Fig. 8d); and the integrity of the breast architecture 
appeared normal without scars, cysts or mass formation 
based on ultrasound. After 3 months, each pig showed a 
normal breast, skin and nipple appearance (Fig. 7g–j).
Immediately after IRE ablation, ultrasound assessment 
indicated that the breast tumors in the rabbit model were 
hypoechoic without contrast enhancement in the abla-
tion zones (Fig.  8a). Elastosonography showed that the 
tumor elasticity value had increased (Fig.  8b, c). Seven 
days after IRE, the tumors were still hypoechoic without 
contrast enhancement, and the elasticity value deter-
mined by elastosonography had decreased (Fig.  8d). All 
of the breast tumors treated with IRE exhibited com-
plete responses, which were confirmed using contrast-
enhanced ultrasound (Fig. 8e, f ) and histopathology.
After IRE, the targeted breast tissues and tumors 
were completely inactivated, which was demonstrated 
using imaging and histopathology, and the only change 
seen for most breast skin was an alteration in color. 
Elastosonograhpic measurements showed that the elas-
ticity of the breast tumors significantly increased after 
IRE, which is consistent with the pathological findings of 
hyperemia and tumor edema.
Discussion
Based on gross pathological, histopathological and imag-
ing (ultrasound/CT/MRI) results, we found that most of 
the experimental animals had well-preserved breast skin, 
and complete ablation of the targeted zones (including 
breast tissue and breast cancer) was achieved. HE stain-
ing, apoptosis assays, color Doppler ultrasound, con-
trast-enhanced ultrasound and ultrasound elastography 
demonstrated the inactivation of breast tumors after IRE. 
The first day after IRE, the stiffness of the breast neo-
plasms significantly increased according to elastosonog-
raphy, which is consistent with the pathological findings 
of hyperemia, edema and stiffness in the breast tumors. 
Normal breast tissue regenerated after IRE ablation of 
Fig. 4 Pathological changes to pig breast after IRE. a Gross pathology. The tissue near the electrode tract had darkened, whereas the tissue far 
from the electrode appeared normal. b (×200): vacuolization in breast acinar epithelial cells with normal mammary gland architecture. c (×200). 
d (×400) Three days after IRE, there was serous fluid in the mammary duct, with exfoliation of epithelial cells and vacuolization, and the tissue 
architecture was normal. e Squamous cells in the breast skin (upper figure ×400) were stained with HE and appeared normal. f Damage to nearby 
striated muscle, with myolysis. g (×400) Ten days after IRE, the mammary duct was normal. h (×100) Ten days after IRE, collagen fibers formed in the 
electrode path. j (×100) Two months after IRE, the breast tissue (acinar, duct) was normal
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Fig. 5 After IRE, apoptosis in the breast was detected. a (×200) Caspase-3 immunohistochemistry and cytosolic staining in ducts and alveoli. b 
(×200) Cytosolic staining was negative in the control group. c (×400) One day after IRE, the TUNEL assays indicated that most nuclei stained posi-
tive, indicating cell apoptosis. d (×400) No apoptosis was observed in the control group (black arrow). e (×400) One week after IRE, the breast tissue 
was normal. f One week after IRE, the architecture and glandular epithelial cells of the sebaceous glands and sweat glands were normal. g The hair 
roots in the breast skin were normal. h (×200) One week after IRE, the squamous epithelial cells in the breast skin were normal
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breast cancer in the rabbit model, without mass formation 
or obvious fibrosis. None of the animals died during IRE.
The number of apoptotic cells in each ablation zone 
increased gradually, reaching a peak on the 3rd day, at 
which point all cells in each ablation zone were apoptotic. 
Following IRE ablation of goat liver, Liu et al. [13]. found 
that the majority of apoptosis occurred 24  h after IRE, 
but there was no detectable apoptosis around the elec-
trode. Apoptosis duration might vary depending on the 
equipment and parameters used. These results are con-
sistent with those obtained from another study [14]. Fur-
thermore, it is notable that, in addition to a slight thermal 
effect in a small region around the electrode, IRE mainly 
affected the central area between the electrodes. Another 
study [15] reported that the average ablation-zone cell 
mortality rate was 77  % at 6  h after IRE and 98  % after 
24 h.
After IRE, the apoptotic cells that were observed in 
the breast tissues were completely absorbed, and nor-
mal breast tissue gradually regenerated without fibro-
sis or mass formation. The ablated breasts subsequently 
became normal in appearance. This regeneration indi-
cates that structural and functional recovery of the breast 
had occurred. Because no additional breast masses devel-
oped, there was no need to discriminate between treat-
ment-related fibrosis and residual tumor. If these findings 
are clinically translatable, this would avoid placing an 
additional psychological burden on the patient. Some 
researchers have demonstrated the efficacy of IRE abla-
tion against breast cancer cell lines in vitro [11, 16, 17], 
but skin and duct damage have not been reported. We 
observed the patency of the mammary duct in this study.
We used different electrodes—monopolar electrode 
in the study, and we believe it is more suitable for breast 
cancer ablation in clinical situation. Robert et  al. [12] 
used bipolar electrode for small breast cancer (less than 
1  cm in diameter), but the ablation volume was limited 
and incomplete ablation occurred in two mice. We used 
monopolar electrodes, which is suitable for breast tumor 
more than 1 cm in diameter with large ablation volume. 
Ablation with multiple monopolar electrodes may full 
cover the tumor, realizing conformal and precise abla-
tion. Also, the State Food and Drug Agency in China usu-
ally recommend rabbit and pig for skin irritation study, 
not mice. By using two or more monopolar electrodes, 
we input electrodes around the tumor. If we use bipolar 
Fig. 6 Apoptosis detected with TUNEL immunohistochemistry (white arrow brown-yellow nuclear staining). a (×400) Immediately after IRE, apop-
tosis of a few cells in the outmost layer of the breast skin squamous epithelial cells was observed. b (×400) Three days after IRE, the apoptosis rate 
increased. c (×400) No apoptosis of the breast skin squamous epithelial cells in the control group was observed. d (×400) Apoptosis of vascular 
smooth muscle cells in the breast
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electrode and insert it in the tumor, it may bring tumor 
cells adhered to the electrode and cause tumor implanta-
tion. In this study, monopolar electrodes may lessen the 
chances of cancer cells adhesion to the electrodes and 
dissemination.
Most of the pig breasts showed no obvious damage to 
the skin architecture after IRE. This phenomenon might 
be explained by the non-simultaneous apoptosis of skin 
squamous epithelial cells and the fast regeneration of 
these cells; additionally, there was no damage to the colla-
gen architecture of the skin. After performing IRE on pig 
breast skin at a skin–electrode distance of 1 or 3 mm, the 
skin color changed; however, this was later completely 
restored to normal, although an occasional infection 
was observed. When the skin–electrode distance was 
5 mm or more, there was no obvious skin damage and no 
purulent skin infection in any of the animals. Erythema 
in breast skin indicates obvious hyperemia in IRE-ablated 
tissue. The breast skin then changes to a purple color 
because red blood cells leak out of capillaries and are 
deposited in and around the ablation zone. Next, hemo-
globin gradually transforms into deoxyhemoglobin, and 
oxygen is released. Thus, we deduced that the observed 
changes in breast skin color were related to changes in 
blood supply in the ablation zone. The skin preservation 
achieved and the lack of mass formation together sup-
port the utility of breast cancer ablation.
Recent studies have reported no significant differ-
ence in overall survival between breast-conserving sur-
gery and radical mastectomy for specific breast cancers, 
which provides theoretical support [1] for the use of local 
ablation to treat breast cancer. After thermal ablation 
Fig. 7 a IRE ablation of pig breast (two arrows) and measurement of the skin–electrode distance. b CT reconstruction of pig breast during IRE with 
parallel electrodes. c Immediately after IRE, there was contrast enhancement and swelling in the breast. d Two hours after IRE, T1WI MR imaging 
showed that the breast was swelling, which was indicated by the low signal intensity. e Two hours after IRE, T2WI MR imaging showed that the 
breast was swollen, with high signal intensity. f Two hours after IRE, contrast-enhanced T1WI MR imaging showed the breast was swelling with 
slight inhomogeneous enhancement. Three months after IRE, T1WI(G), T2WI(H) and contrast-enhanced T1WI(J) MR imaging showed that the breast, 
skin and nipple of the pig were normal
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of breast cancer, independent of supplementary post-
operative radiotherapy, some breast masses will form 
and slowly resolve, causing some patients to experience 
anxiety [2] and potentially leading to infection or fibrotic 
mass formation in the breast. Skin injury and scar for-
mation are also limited when using radiotherapy and 
repeated thermal ablation for breast cancer, particularly 
when the tumor being treated is superficial. Previous 
reports [2] have shown damage to the skin and pectoralis 
major after breast ablation, and it can be difficult to dif-
ferentiate between a scar and a residual tumor or a recur-
rence [18].
The IRE electrode has a 19G diameter, which helps 
reduce puncture injury and hemorrhage during breast 
ablation. However, during IRE, two small electrodes are 
placed in parallel with a corresponding angle and depth, 
which might increase the puncture rate and lead to dam-
age. In this study, there were two cases of skin infection 
in the electrode tract, which might have resulted from 
mechanical injury and possible thermal damage [19] 
around the electrode ablation zone. Furthermore, disin-
fecting the animals was difficult, especially when an abla-
tion zone was located near a fold in the skin. Skin burns 
are one of the most common complications after thermal 
ablation [20], although if the IRE parameters are well 
controlled, thermal damage can be avoided [21, 22].
After the thermal ablation of a breast tumor, the 
lesion became hyperechoic, which affects efficacy 
Fig. 8 Contrast-enhanced ultrasound and elastosonography before and after IRE ablation of breast cancer in a rabbit model. a, b Ultrasound and 
elastosonography before IRE showed the echo and rigidity of the ablation zone. c, d After IRE, elastosonography led to an increase in the rigidity 
value (1 day after IRE), followed by a decrease (7 days after IRE). e Based on contrast-enhanced ultrasound after IRE, there was no enhancement in 
the ablation zone (1 day after). f Based on contrast-enhanced ultrasound, 7 days after IRE, the area without blood supply had enlarged
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judgment and real-time monitoring. Although cryoab-
lation probes are relatively small and ice ball formation 
can be monitored using ultrasound, this approach can 
also activate anti-tumor immunity [23]. High-inten-
sity focused ultrasound also has some disadvantages, 
including that it is time-consuming, increases the risk 
of target motion due to pain and discomfort (which 
could affect treatment accuracy and cause damage to 
surrounding sensitive structures), and is expensive [24]. 
However, after IRE, the ablation area becomes hypo-
echoic, facilitating real-time ultrasound-based monitor-
ing during breast ablation.
In our studies, lesion size and shape were determined 
by elastography and contrast-enhanced ultrasound, 
and these parameters were well correlated with the area 
of cell apoptosis determined by pathology. Contrast-
enhanced ultrasound can be used to assess whether the 
complete ablation of a breast cancer has been achieved 
by detecting the blood supply in the ablation zone, as 
reported in many previous studies [25, 26]. Immedi-
ately after IRE ablation for breast cancer, increased tis-
sue stiffness, assessed using elastography, was indicative 
of edema, congestion and cell death. Elastography might 
complement the use of contrast-enhanced ultrasound 
to monitor IRE [27]. Timely assessment of IRE ablation 
might also reduce the possibility of a residual tumor. The 
presence of mild hyperemia and edema in the pig breast, 
as well as complete ablation (Additional file 1) of the tar-
geted tissue and breast recovery, were also demonstrated 
on contrast-enhancement CT and MRI in our study.
Conclusions
Our study demonstrated that IRE ablation of breast tis-
sue and breast cancer is feasible and safe. After the com-
plete ablation of breast tissue and breast cancer with IRE, 
the skin architecture was well preserved at a skin–electrode 
distance of ≥5 mm. In addition, rapid dissipation of apop-
totic tissue and breast regeneration occurred in the experi-
mental animals without massive fibrosis or mass formation.
IRE is a potential option for the ablation of breast can-
cer, particularly for superficial tumors that are in close 
proximity to susceptible skin.
Due to anatomical differences between humans and 
animals, clinical trials will be necessary to further assess 
the skin changes that occur after IRE ablation of breast 
cancer.
Additional file
Additional file 1. The setting voltage and current were successfully 
delivered after IRE, which means irrecoverable pores in the cell membrane 
were created—a sign of successful ablation of targeted volume.
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